0001478242-23-000091.txt : 20230921 0001478242-23-000091.hdr.sgml : 20230921 20230921170136 ACCESSION NUMBER: 0001478242-23-000091 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230919 FILED AS OF DATE: 20230921 DATE AS OF CHANGE: 20230921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Panagos Constantinos CENTRAL INDEX KEY: 0001917705 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35907 FILM NUMBER: 231269677 MAIL ADDRESS: STREET 1: 4280 EMPEROR BLVD CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IQVIA HOLDINGS INC. CENTRAL INDEX KEY: 0001478242 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 271341991 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2400 ELLIS ROAD CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-998-2000 MAIL ADDRESS: STREET 1: 2400 ELLIS ROAD CITY: DURHAM STATE: NC ZIP: 27703 FORMER COMPANY: FORMER CONFORMED NAME: Quintiles IMS Holdings, Inc. DATE OF NAME CHANGE: 20161003 FORMER COMPANY: FORMER CONFORMED NAME: Quintiles Transnational Holdings Inc. DATE OF NAME CHANGE: 20091208 4 1 wk-form4_1695330080.xml FORM 4 X0508 4 2023-09-19 0 0001478242 IQVIA HOLDINGS INC. IQV 0001917705 Panagos Constantinos C/O IQVIA HOLDINGS INC. 2400 ELLIS ROAD DURHAM NC 27703 0 1 0 0 See Remarks 0 Common Stock 2023-09-19 4 S 0 19898 208.69 D 14250 D Common Stock 2023-09-19 4 M 0 2853 95.23 A 17103 D Common Stock 2023-09-19 4 M 0 7681 131.82 A 24784 D Common Stock 2023-09-19 4 M 0 11202 161.70 A 35986 D Common Stock 2023-09-19 4 M 0 4450 183.82 A 40436 D Common Stock 2023-09-19 4 S 0 7419 208.63 D 33017 D Common Stock 2023-09-19 4 D 0 18767 208.56 D 14250 D Stock Appreciation Right 95.23 2023-09-19 4 M 0 2853 0 D 2021-02-08 2028-02-08 Common Stock 2853 0 D Stock Appreciation Right 131.82 2023-09-19 4 M 0 7681 0 D 2022-02-13 2029-02-13 Common Stock 7681 0 D Stock Appreciation Right 161.70 2023-09-19 4 M 0 11202 0 D 2023-02-11 2030-02-11 Common Stock 11202 0 D Stock Appreciation Right 183.82 2023-09-19 4 M 0 4450 0 D 2023-02-09 2031-02-09 Common Stock 4450 2225 D The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $207.78 to $210.33 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $207.71 to $210.12 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. President, Research & Development Solutions /s/ Matthew Gilmartin, Attorney-in-Fact for Costa Panagos 2023-09-21